Showing results (191-200 of 219) with videos related to
Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort studyKarlijn de Joode, Daphne W Dumoulin, Jolien Tol, et al.International Journal of Cancer|October 16, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancerArd van Veelen, G D Marijn Veerman, Marjon V Verschueren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2026
First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-AnalysisLeonardo Brunetti, Giacomo Colella, Giuseppina Rita Di Fazio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2023
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I StudyLuis Paz-Ares, Stephane Champiat, W Victoria Lai, et al.Lung Cancer (Amsterdam, Netherlands)|June 12, 2022
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) surveySara Pilotto, Alice Avancini, Jessica Menis, et al.Ecancermedicalscience|March 4, 2026
Oncology with common sense: beyond biologistic and pharmacological modelsRodrigo Lastra, Patricia Iranzo, Javier-David Benítez-Fuentes, et al.Plos One|May 6, 2009
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expressionRafael Rosell, Laia Perez-Roca, Jose Javier Sanchez, et al.Lung Cancer (Amsterdam, Netherlands)|November 30, 2024
Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trialsHaiyan Zeng, Sanne B Schagen, Lizza E L Hendriks, et al.Pageof 22